# Progress Note 05 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Frances Burney (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN013-SYN
- Date: 2026-10-29
- Fictional facility: St. Posthumous Health Center
- Fictional author: Harriet Pell, MD
- Calendar frame: modern shifted

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning) on the same day

## Chief complaint

Adult preventive visit; no new complaints. **S**

## History of present illness

Mrs. Burney returns for her yearly preventive visit, ten days after starting anastrozole and four weeks after her right mastectomy. The seroma did not recur after one aspiration, and her wound has healed. Her shoulder movement is nearly full with daily exercises. She has had no hot flashes or joint aches yet on anastrozole and takes vitamin D daily. She walks 30 minutes a day and has begun writing again in the mornings. She completed the health risk assessment before the visit. **S**

| Element | Detail |
|---|---|
| Visit | Adult preventive visit, age 59 |
| Active conditions | Right breast cancer after mastectomy, on anastrozole; low bone mass |
| Medicines | Anastrozole 1 mg daily; vitamin D3 1000 units daily |
| Recent events | Seroma aspirated once, three weeks ago; resolved |
| Functional status | Independent; walking 30 minutes a day |

## Health risk assessment

Completed by the patient before the visit and reviewed during the visit. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good, and recovering well from surgery |
| Psychosocial | Close to her husband and son; many friends visit; no financial strain; feels safe at home |
| Behavioral | Never smoker; a glass of wine with dinner two or three times a week; walks 30 minutes a day; diet with dairy most days |
| Activities of daily living | Independent in all |
| Instrumental activities of daily living | Manages her own medicines, money, correspondence, and household |
| Home safety | Smoke detectors working; wears a seat belt; no falls |
| Hearing and vision | Reading glasses; eye examination last year; no hearing concern |
| Sleep | About seven hours a night |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; no fever or night sweats |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | No hearing change |
| Cardiovascular | Negative | No chest pain, palpitations, or leg swelling |
| Respiratory | Negative | No cough or breathlessness |
| Breast | Negative | No lump or change in the left breast; right chest wall healing |
| Gastrointestinal | Negative | Regular bowels; no blood |
| Genitourinary | Negative | No vaginal bleeding, dryness, or urinary symptoms |
| Musculoskeletal | Negative | No joint aches or bone pain; right shoulder nearly full movement |
| Integumentary | Negative | Wound healed; no new skin lesions |
| Neurological | Negative | No numbness of the arm beyond a small patch under the axilla |
| Psychiatric | Negative | Mood good; PHQ-2 score 0 |

12 systems reviewed. **S**

## Current medications

- Anastrozole 1 mg oral tablet, one tablet by mouth once daily, planned for five years **S**
- Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 120/76 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 61.2 kg; BMI 23.9 kg/m². All vital signs are synthetic.

PHQ-2: 0; AUDIT-C: 2. All results are synthetic.

## Change since baseline

- PHQ-2: 1 at baseline, 0 at this visit **S**

## Immunizations given today

- Influenza vaccine, 2026-2027 season **S**
- Pneumococcal conjugate vaccine PCV20 **S**
- Recombinant zoster vaccine, dose 1 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well-appearing; BMI 23.9 |
| Eyes | Pupils equal and reactive |
| Neck | No thyroid enlargement or nodes |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Respiratory | Clear |
| Breasts and chest wall | Right mastectomy scar healed; flap flat with no fluid; left breast without masses |
| Lymph nodes | No axillary or supraclavicular nodes |
| Extremities | Arm circumference 26.0 cm on each side 10 cm above the elbow; right shoulder flexion 165 degrees |
| Abdomen | Soft; no masses |
| Skin | No suspicious lesions |
| Psychiatric | Bright, observant, and engaged |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Adult preventive visit completed**. Health risk assessment reviewed and a written prevention plan given. Depression screen negative; AUDIT-C 2, below the threshold for women. **S**
   - Next preventive visit in one year.
2. **Right breast cancer after mastectomy, on anastrozole** (C50.411). Recovering well; no side effects of anastrozole yet. **S**
   - Continue anastrozole and vitamin D.
   - Survivorship visit in three months.
3. **Cardiovascular risk**. LDL cholesterol 132 mg/dL, total 214, HDL 58 ten days ago; blood pressure 120/76; non-smoker; no diabetes. Estimated 10-year cardiovascular risk below 5 percent. **S**
   - No statin; diet and activity.
   - Lipids rechecked yearly on anastrozole.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, 2026-2027 | Completed today | Inactivated vaccine given today |
| Pneumococcal vaccine | Completed today | PCV20 given today; recommended from age 50; no further doses needed |
| Recombinant zoster vaccine | Completed today | Dose 1 today; dose 2 in two to six months |
| COVID-19 vaccine, 2026-2027 | Due | Recommended; she will get it at her pharmacy in two weeks |
| Hepatitis B vaccine | Due | Recommended for adults 19 to 59; series to start at the next visit if the screening test shows no immunity |
| Tetanus booster | Up to date | Tdap six and a half years ago |
| Breast cancer screening | Not indicated | Replaced by surveillance: yearly diagnostic mammogram of the left breast from next August |
| Cervical cancer screening | Up to date | Cytology with HPV co-testing three years ago, normal; next in two years |
| Colorectal cancer screening | Up to date | Colonoscopy eight years ago, normal; next at ten years |
| Osteoporosis screening | Up to date | DXA ten days ago: low bone mass; repeat in two years on anastrozole |
| Hepatitis B, hepatitis C, and HIV screening | Ordered | One-time screening; no prior result on record; drawn today, results pending |
| Cholesterol screening and statin decision | Completed today | Lipid panel ten days ago reviewed; 10-year risk below 5 percent; no statin |
| Diabetes screening | Not indicated | BMI 23.9 without other risk factors |
| Lung cancer screening | Not indicated | Never smoker |
| Blood pressure screening | Completed today | 120/76 mmHg |
| Depression screening | Completed today | PHQ-2 score 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C 2, negative |
| Physical activity and diet counseling | Completed today | 150 minutes of walking a week, strength exercise twice a week once the surgeon allows, and calcium from food |

## Advance care planning

Voluntary advance care planning discussion of about 20 minutes, with her consent, prompted by her cancer diagnosis. She has named a health care agent and completed a written health care directive today, now scanned into the chart. She wants to be told plainly and in advance what any treatment would involve. If the cancer returned she would want treatment that offered a real chance of control while she could still live independently and write; she would not want resuscitation or prolonged life support if recovery to independent life were not expected. **S**

## Guideline basis

- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Hepatitis B, hepatitis C, and HIV results by portal message. Second zoster dose in two to six months. Survivorship visit in three months. **S**

